Profile picture

Doctor F Daniel Ramirez

University of Ottawa Heart Institute, Ottawa (Canada)
Follow
Logo ESC

Contributor content

Validation of the PADIT (prevention of arrhythmia device infection trial) risk score for infection and infection subtypes
Journal
Validation of the PADIT (prevention of arrhythmia device infection trial) risk score for infection and infection subtypes
29 January 2026
Report of cardiac electronic device implant complications over a 7-year study period
Journal
Report of cardiac electronic device implant complications over a 7-year study period
28 October 2024
Optimal interlesion distance for 90 and 50 watt radiofrequency applications with low ablation index values: experimental findings in a chronic ovine model
Journal
Optimal interlesion distance for 90 and 50 watt radiofrequency applications with low ablation index values: experimental findings in a chronic ovine model
18 October 2023
Purkinje network and myocardial substrate at the onset of human ventricular fibrillation: implications for catheter ablation
Journal
Purkinje network and myocardial substrate at the onset of human ventricular fibrillation: implications for catheter ablation
4 February 2022
The association between mean arterial pressure and outcomes in patients with cardiogenic shock: insights from the DOREMI trial
Journal
The association between mean arterial pressure and outcomes in patients with cardiogenic shock: insights from the DOREMI trial
12 August 2021
Pulsed field ablation prevents chronic atrial fibrotic changes and restrictive mechanics after catheter ablation for atrial fibrillation
Journal
Pulsed field ablation prevents chronic atrial fibrotic changes and restrictive mechanics after catheter ablation for atrial fibrillation
8 July 2021
Bang for the buck: the importance of modifiable factors for electrical cardioversion of atrial fibrillation
Journal
Bang for the buck: the importance of modifiable factors for electrical cardioversion of atrial fibrillation
7 November 2019

ESC 365 is supported by